GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
3.190
+0.180 (5.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $7.13 million as of November 21, 2024. Its market cap has decreased by -38.76% in one year.
Market Cap
7.13M
Enterprise Value
710.51K
1-Year Change
-38.76%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $7.13M, a decrease of -99.24%. That is a compound annual growth rate of -11.19%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptose Biosciences | 6.70M |
| NewGenIvf Group | 6.61M |
| Healthcare Triangle | 6.57M |
| Cutera | 6.56M |
| Addex Therapeutics | 6.53M |
| Cyclerion Therapeutics | 6.49M |
| BioCardia | 6.48M |
| Brainstorm Cell Therapeutics | 6.43M |